Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature

References

• Sheybani A, Lenzhofer M, Hohensinn M, Reitsamer H, Ahmed II. Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg. 2015;41(9):1905–1909. doi:10.1016/j.jcrs.2015.01.019
   PubMed Web of Science ®Google Scholar
• Lenzhofer M, Strohmaier C, Hohensinn M, et al. Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation. Acta Ophthalmol. 2019;97(2):e231–e237. doi:10.1111/aos.13902
   PubMed Web of Science ®Google Scholar
• Shaarawy TM, Moschos MM, Sherwood MB. New glaucoma surgical alternatives. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, editors. Glaucoma. 2nd ed. London, England, UK: Elsevier/Saunders; 2015:1188–1201.
   Google Scholar
• Rather PA, Vold S, McFarland M. Twelve-month outcomes of an ab interno gelatin stent combined with cataract surgery or as a standalone procedure in pseudophakic eyes with open-angle glaucoma. J Cataract Refract Surg. 2020;46(8):1172–1177. doi:10.1097/j.jcrs.0000000000000286
   PubMed Web of Science ®Google Scholar
• Fea AM, Bron AM, Economou MA, et al. European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma. J Cataract Refract Surg. 2020;46(3):441–450. doi:10.1097/j.jcrs.0000000000000065
   PubMed Web of Science ®Google Scholar
• Panarelli JF, Yan DB, Francis B, Craven ER. XEN gel stent open conjunctiva technique: a practical approach paper. Adv Ther. 2020;37(5):2538–2549. doi:10.1007/s12325-020-01278-1
   PubMed Web of Science ®Google Scholar
• Lewis RA. Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg. 2014;40(8):1301–1306. doi:10.1016/j.jcrs.2014.01.032
   PubMed Web of Science ®Google Scholar
• Sheybani A, Reitsamer H, Ahmed II. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci. 2015;56(8):4789–4795. doi:10.1167/iovs.15-16625
   PubMed Web of Science ®Google Scholar
• McLaren JW. Measurement of aqueous humor flow. Exp Eye Res. 2009;88(4):641–647. doi:10.1016/j.exer.2008.10.018
   PubMed Web of Science ®Google Scholar
• Mansouri K, Guidotti J, Rao HL, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. 2018;27(2):140–147. doi:10.1097/ijg.0000000000000858
   PubMed Web of Science ®Google Scholar
• Mansouri K, Gillmann K, Rao HL, Guidotti J, Mermoud A. Prospective evaluation of XEN gel implant in eyes with pseudoexfoliative glaucoma. J Glaucoma. 2018;27(10):869–873. doi:10.1097/ijg.0000000000001045
   PubMed Web of Science ®Google Scholar
• Reitsamer H, Vera V, Ruben S, et al. Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study. Acta Ophthalmol. 2022;100(1):e233–e245. doi:10.1111/aos.14886
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–814.e1. doi:10.1016/j.ajo.2011.10.024
   PubMed Web of Science ®Google Scholar
• Zahid S, Musch DC, Niziol LM, Lichter PR. Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2013;155(4):674–680, 680.e1. doi:10.1016/j.ajo.2012.10.017
   PubMed Web of Science ®Google Scholar
• Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36. doi:10.1016/j.ajo.2017.07.023
   PubMed Web of Science ®Google Scholar
• Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–1588. doi:10.1016/j.ophtha.2017.05.004
   PubMed Web of Science ®Google Scholar
• Lenzhofer M, Strohmaier C, Hohensinn M, et al. Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2019;257(12):2707–2715. doi:10.1007/s00417-019-04452-6
   PubMed Web of Science ®Google Scholar
• Urcola A, Garay-Aramburu G. Safety and efficacy of bilateral simultaneous XEN implant surgery: a pilot study. Int Ophthalmol. 2021;41(3):859–866. doi:10.1007/s10792-020-01640-w
   PubMed Web of Science ®Google Scholar
• Tan NE, Tracer N, Terraciano A, Parikh HA, Panarelli JF, Radcliffe NM. Comparison of safety and efficacy between ab interno and ab externo approaches to XEN gel stent placement. Clin Ophthalmol. 2021;15:299–305. doi:10.2147/opth.s292007
   PubMed Web of Science ®Google Scholar
• Ucar F, Cetinkaya S. Xen implantation in patients with primary open-angle glaucoma: comparison of two different techniques. Int Ophthalmol. 2020;40(10):2487–2494. doi:10.1007/s10792-020-01427-z
   PubMed Web of Science ®Google Scholar
• Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Bilateral XEN stent implantation: a long-term prospective study of the difference in outcomes between first-operated and fellow eyes. J Glaucoma. 2020;29(7):536–541. doi:10.1097/ijg.0000000000001520
   PubMed Web of Science ®Google Scholar
• Gillmann K, Bravetti GE, Mermoud A, Rao HL, Mansouri K. XEN gel stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation. J Glaucoma. 2019;28(8):676–684. doi:10.1097/ijg.0000000000001295
   PubMed Web of Science ®Google Scholar
• Vera V, Shah M. Navigating challenges after xen. Curr Trends Ophthalmol. 2021;4(1):17. doi:10.18314/ctoy.v4i1.2078
   Google Scholar
• Barão RC, José P, Teixeira FJ, Ferreira NP, Sens P, Pinto LA. Automated gonioscopy assessment of XEN45 gel stent angle location after isolated XEN or combined phaco-XEN procedures: clinical implications. J Glaucoma. 2020;29(10):932–940. doi:10.1097/ijg.0000000000001582
   PubMed Web of Science ®Google Scholar
• Başer EF, Seymenoğlu RG. Results of fluorouracil-augmented Xen45 implantation in primary open-angle and pseudoexfoliation glaucoma. Int Ophthalmol. 2021;41(3):945–955. doi:10.1007/s10792-020-01650-8
   PubMed Web of Science ®Google Scholar
• Buffault J, Graber M, Bensmail D, et al. Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep. 2020;10(1):4527. doi:10.1038/s41598-020-61319-1
   PubMed Web of Science ®Google Scholar
• Busch T, Skiljic D, Rudolph T, Bergström A, Zetterberg M. Learning curve and one-year outcome of XEN 45 gel stent implantation in a Swedish population. Clin Ophthalmol. 2020;14:3719–3733. doi:10.2147/opth.s267010
   PubMed Web of Science ®Google Scholar
• Chao YJ, Ko YC, Chen MJ, Lo KJ, Chang YF, Liu CJ. XEN45 Gel Stent implantation in eyes with primary open angle glaucoma: a study from a single hospital in Taiwan. J Chin Med Assoc. 2021;84(1):108–113. doi:10.1097/jcma.0000000000000430
   PubMed Web of Science ®Google Scholar
• Cutolo CA, Iester M, Bagnis A, et al. Early postoperative intraocular pressure is associated with better pressure control after XEN implantation. J Glaucoma. 2020;29(6):456–460. doi:10.1097/ijg.0000000000001501
   PubMed Web of Science ®Google Scholar
• De Gregorio A, Pedrotti E, Russo L, Morselli S. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol. 2018;38(3):1129–1134. doi:10.1007/s10792-017-0571-x
   PubMed Web of Science ®Google Scholar
• Fea AM, Spinetta R, Cannizzo PML, et al. Evaluation of bleb morphology and reduction in IOP and glaucoma medication following implantation of a novel gel stent. J Ophthalmol. 2017;2017:9364910. doi:10.1155/2017/9364910
   PubMed Web of Science ®Google Scholar
• Fernández-García A, Zhou Y, García-Alonso M, Andrango HD, Poyales F, Garzón N. Medium-term clinical outcomes following Xen45 device implantation. Int Ophthalmol. 2020;40(3):709–715. doi:10.1007/s10792-019-01232-3
   PubMed Web of Science ®Google Scholar
• Gabbay IE, Allen F, Morley C, Pearsall T, Bowes OM, Ruben S. Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol. 2020;104(8):1125–1130. doi:10.1136/bjophthalmol-2019-313870
   PubMed Web of Science ®Google Scholar
• Gabbay IE, Goldberg M, Allen F, et al. Efficacy and safety data for the Ab interno XEN45 gel stent implant at 3 years: a retrospective analysis. Eur J Ophthalmol. 2021;11206721211014381. doi:10.1177/11206721211014381
   Web of Science ®Google Scholar
• Galal A, Bilgic A, Eltanamly R, Osman A. XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol. 2017;2017:5457246. doi:10.1155/2017/5457246
   PubMed Web of Science ®Google Scholar
• Gernhart M, Hohberger B, Laemmer R. Two-Year Follow-Up: therapeutic Success with Respect to Axial Length of Stand-Alone Xen45 Gel Stent Implantation and Combined Procedures. Einfluss der Achsenlänge auf die 2-Jahres-Erfolgsrate der Stand-alone- und mit Phako/HKL kombinierten Xen45-Gel-Stent implantation. Klin Monbl Augenheilkd. 2021;238(11):1240–1247. doi:10.1055/a-1328-2847
   PubMedGoogle Scholar
• Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors. Acta Ophthalmol. 2021;99(4):e531–e539. doi:10.1111/aos.14605
   PubMed Web of Science ®Google Scholar
• Heidinger A, Schwab C, Lindner E, Riedl R, Mossböck G. A retrospective study of 199 Xen45 stent implantations from 2014 to 2016. J Glaucoma. 2019;28(1):75–79. doi:10.1097/ijg.0000000000001122
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I. Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26(12):1130–1136. doi:10.1097/ijg.0000000000000803
   PubMed Web of Science ®Google Scholar
• Hong K, Lind J, Sheybani A. Safety and efficacy outcomes of the Xen45 gel stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital. Eye Vis. 2020;7:5. doi:10.1186/s40662-019-0171-0
   PubMedGoogle Scholar
• Hu JY, Ang BCH, Yip LW. Efficacy of the XEN gel stent on intraocular pressure lowering in East Asian eyes. Int Ophthalmol. 2020;40(5):1191–1199. doi:10.1007/s10792-020-01284-w
   PubMed Web of Science ®Google Scholar
• Ibáñez-Muñoz A, Soto-Biforcos VS, Chacón-González M, et al. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol. 2019;29(3):309–314. doi:10.1177/1120672118795063
   PubMed Web of Science ®Google Scholar
• Ibáñez-Muñoz A, Soto-Biforcos VS, Rodríguez-Vicente L, et al. XEN implant in primary and secondary open-angle glaucoma: a 12-month retrospective study. Eur J Ophthalmol. 2020;30(5):1034–1041. doi:10.1177/1120672119845226
   PubMed Web of Science ®Google Scholar
• Kalina AG, Kalina PH, Brown MM. XEN(®) gel stent in medically refractory open-angle glaucoma: results and observations after one year of use in the United States. Ophthalmol Ther. 2019;8(3):435–446. doi:10.1007/s40123-019-0192-8
   PubMed Web of Science ®Google Scholar
• Karimi A, Hopes M, Martin KR, Lindfield D. Efficacy and safety of the ab-interno xen gel stent after failed trabeculectomy. J Glaucoma. 2018;27(10):864–868. doi:10.1097/ijg.0000000000001044
   PubMed Web of Science ®Google Scholar
• Karimi A, Lindfield D, Turnbull A, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye. 2019;33(3):469–477. doi:10.1038/s41433-018-0243-8
   PubMed Web of Science ®Google Scholar
• Laborda-Guirao T, Cubero-Parra JM, Hidalgo-Torres A. Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study. Int J Ophthalmol. 2020;13(8):1250–1256. doi:10.18240/ijo.2020.08.11
   PubMed Web of Science ®Google Scholar
• Laroche D, Nkrumah G, Ng C. Real-world retrospective consecutive study of ab interno XEN 45 gel stent implant with mitomycin C in black and Afro-Latino patients with glaucoma: 40% required secondary glaucoma surgery at 1 year. Middle East Afr J Ophthalmol. 2019;26(4):229–234. doi:10.4103/meajo.MEAJO_126_19
   PubMed Web of Science ®Google Scholar
• Lewczuk K, Konopińska J, Jabłońska J, et al. XEN glaucoma implant for the management of operated uncontrolled glaucoma: results and complications during a long-term follow-up. J Ophthalmol. 2021;2021:2321922. doi:10.1155/2021/2321922
   PubMed Web of Science ®Google Scholar
• Mansouri K, Bravetti GE, Gillmann K, Rao HL, Ch’ng TW, Mermoud A. Two-year outcomes of XEN gel stent surgery in patients with open-angle glaucoma. Ophthalmol Glaucoma. 2019;2(5):309–318. doi:10.1016/j.ogla.2019.03.011
   PubMedGoogle Scholar
• Nuzzi R, Gremmo G, Toja F, Marolo P. A retrospective comparison of trabeculectomy, baerveldt glaucoma implant, and microinvasive glaucoma surgeries in a three-year follow-up. Semin Ophthalmol. 2021;36(8):839–849. doi:10.1080/08820538.2021.1931356
   PubMed Web of Science ®Google Scholar
• Olgun A, Aktas Z, Ucgul AY. XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma. Int Ophthalmol. 2020;40(5):1085–1093. doi:10.1007/s10792-019-01271-w
   PubMed Web of Science ®Google Scholar
• Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M, et al. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Cirugía combinada mediante facoemulsificación e implante XEN45 con acceso temporal y 2 únicas incisiones. Arch Soc Esp Oftalmol. 2016;91(9):415–421. doi:10.1016/j.oftal.2016.02.006
   PubMedGoogle Scholar
• Poelman HJ, Pals J, Rostamzad P, Bramer WM, Wolfs RCW, Ramdas WD. Efficacy of the XEN-implant in glaucoma and a meta-analysis of the literature. J Clin Med. 2021;10(5):1118. doi:10.3390/jcm10051118
   PubMed Web of Science ®Google Scholar
• Post M, Lubiński W, Śliwiak D, Podborączyńska-Jodko K, Mularczyk M. XEN Gel Stent in the management of primary open-angle glaucoma. Doc Ophthalmol. 2020;141(1):65–76. doi:10.1007/s10633-020-09753-4
   PubMed Web of Science ®Google Scholar
• Qureshi A, Jones NP, Au L. Urgent management of secondary glaucoma in uveitis using the Xen-45 gel stent. J Glaucoma. 2019;28(12):1061–1066. doi:10.1097/ijg.0000000000001389
   PubMed Web of Science ®Google Scholar
• Rauchegger T, Angermann R, Willeit P, Schmid E, Teuchner B. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Acta Ophthalmol. 2021;99(4):369–375. doi:10.1111/aos.14627
   PubMed Web of Science ®Google Scholar
• Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–996. doi:10.1007/s00417-019-04251-z
   PubMed Web of Science ®Google Scholar
• Schargus M, Theilig T, Rehak M, Busch C, Bormann C, Unterlauft JD. Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma. BMC Ophthalmol. 2020;20(1):490. doi:10.1186/s12886-020-01764-8
   PubMed Web of Science ®Google Scholar
• Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, et al. XEN(®) Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433–e440. doi:10.1111/aos.14602
   PubMed Web of Science ®Google Scholar
• Sharpe R, Pham G, Chang P. Comparison of ab interno XEN gelatin stent vs trabeculectomy with mitomycin C: a retrospective study. J Curr Glaucoma Pract. 2020;14(3):87–92. doi:10.5005/jp-journals-10078-1287
   PubMedGoogle Scholar
• Smith M, Charles R, Abdel-Hay A, et al. 1-year outcomes of the Xen45 glaucoma implant. Eye. 2019;33(5):761–766. doi:10.1038/s41433-018-0310-1
   PubMed Web of Science ®Google Scholar
• Sng CCA, Chew PTK, Htoon HM, Lun K, Jeyabal P, Ang M. Case series of combined XEN implantation and phacoemulsification in Chinese eyes: one-year outcomes. Adv Ther. 2019;36(12):3519–3529. doi:10.1007/s12325-019-01127-w
   PubMed Web of Science ®Google Scholar
• Stoner AM, Capitena Young CE, SooHoo JR, et al. A comparison of clinical outcomes after XEN gel stent and EX-PRESS glaucoma drainage device implantation. J Glaucoma. 2021;30(6):481–488. doi:10.1097/ijg.0000000000001823
   PubMed Web of Science ®Google Scholar
• Subaşı S, Yüksel N, Özer F, Yılmaz Tugan B, Pirhan D. A retrospective analysis of safety and efficacy of XEN 45 microstent combined cataract surgery in open-angle glaucoma over 24 months. Turk J Ophthalmol. 2021;51(3):139–145. doi:10.4274/tjo.galenos.2020.47629
   PubMedGoogle Scholar
• Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye. 2018;32(2):324–332. doi:10.1038/eye.2017.162
   PubMed Web of Science ®Google Scholar
• Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep. 2020;10(1):19337. doi:10.1038/s41598-020-76551-y
   PubMed Web of Science ®Google Scholar
• Theillac V, Blumen-Ohana E, Akesbi J, et al. Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study. BMC Ophthalmol. 2020;20(1):231. doi:10.1186/s12886-020-01492-z
   PubMed Web of Science ®Google Scholar
• Wałek E, Przeździecka-Dołyk J, Helemejko I, Misiuk-Hojło M. Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation. Int Ophthalmol. 2020;40(1):235–246. doi:10.1007/s10792-019-01168-8
   PubMed Web of Science ®Google Scholar
• Widder RA, Lappas A, Rennings C, Hild M, Dietlein TS, Roessler GF. Primary versus posttrabeculectomy XEN45 gel stent implantation: comparison of success rates and intraocular pressure-lowering potential in pseudophakic eyes. J Glaucoma. 2020;29(12):1115–1119. doi:10.1097/ijg.0000000000001649
   PubMed Web of Science ®Google Scholar
• Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;2005(4):Cd002897. doi:10.1002/14651858.CD002897.pub2
   PubMedGoogle Scholar
• Widder RA, Dietlein TS, Dinslage S, Kühnrich P, Rennings C, Rössler G. The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):765–771. doi:10.1007/s00417-018-3899-7
   PubMed Web of Science ®Google Scholar
• Marcos Parra MT, Salinas López JA, López Grau NS, Ceausescu AM, Pérez Santonja JJ. XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2019;257(8):1741–1750. doi:10.1007/s00417-019-04341-y
   PubMed Web of Science ®Google Scholar
• Sheybani A. Prospective, randomized, multicenter, open-label, 12-month evaluation of the effectiveness and safety of the gel stent vs trabeculectomy: the Gold Standard Pathway Study (GPS). Presented at: American Glaucoma Society; 2022; Orlando, Florida.
   Google Scholar
• Wagner FM, Schuster AK, Emmerich J, Chronopoulos P, Hoffmann EM. Efficacy and safety of XEN®-implantation vs. trabeculectomy: data of a “real-world” setting. PLoS One. 2020;15(4):e0231614. doi:10.1371/journal.pone.0231614
   PubMed Web of Science ®Google Scholar
• Wanichwecharungruang B, Ratprasatporn N. 24-month outcomes of XEN45 gel implant versus trabeculectomy in primary glaucoma. PLoS One. 2021;16(8):e0256362. doi:10.1371/journal.pone.0256362
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/s0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115(7):1123–1129.e3. doi:10.1016/j.ophtha.2007.10.031
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(11):1965–1972. doi:10.1016/j.ophtha.2007.03.016
   PubMed Web of Science ®Google Scholar
• Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(2):205–209. doi:10.1016/j.ophtha.2006.07.060
   PubMed Web of Science ®Google Scholar
• Kim JH, Rabiolo A, Morales E, et al. Risk factors for fast visual field progression in glaucoma. Am J Ophthalmol. 2019;207:268–278. doi:10.1016/j.ajo.2019.06.019
   PubMed Web of Science ®Google Scholar
• Konstas AG, Topouzis F, Leliopoulou O, et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology. 2006;113(5):761–5.e1. doi:10.1016/j.ophtha.2006.01.029
   PubMed Web of Science ®Google Scholar
• Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;(9):Cd004399. doi:10.1002/14651858.CD004399.pub3
   PubMed Web of Science ®Google Scholar
• Midha N, Gillmann K, Chaudhary A, Mermoud A, Mansouri K. Efficacy of needling revision after XEN gel stent implantation: a prospective study. J Glaucoma. 2020;29(1):11–14. doi:10.1097/ijg.0000000000001394
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth G, Conrad-Hengerer I. Comparison of minimally invasive XEN45 gel stent implantation in glaucoma patients without and with prior interventional therapies. Ophthalmol Ther. 2019;8(3):447–459. doi:10.1007/s40123-019-0193-7
   PubMed Web of Science ®Google Scholar
• Hohberger B, Welge-Lüßen UC, Lämmer R. MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2018;256(3):621–625. doi:10.1007/s00417-017-3895-3
   PubMed Web of Science ®Google Scholar
• Berdahl JP. Cataract surgery to lower intraocular pressure. Middle East Afr J Ophthalmol. 2009;16(3):119–122. doi:10.4103/0974-9233.56222
   PubMedGoogle Scholar
• Weinreb RN, Ramulu P, Topouzis F, et al. 11th Consensus Meeting: Glaucoma Surgery. Kugler Publications; 2019. WGA Consensus Series.
   Google Scholar
• Dar N, Sharon T, Hecht I, Kalev-Landoy M, Burgansky-Eliash Z. Efficacy and safety of the ab interno gelatin stent in severe pseudoexfoliation glaucoma compared to non-pseudoexfoliation glaucoma at 6 months. Eur J Ophthalmol. 2020;30(5):1028–1033. doi:10.1177/1120672119848277
   PubMed Web of Science ®Google Scholar
• Hengerer FH, Auffarth GU, Yildirim TM, Conrad-Hengerer I. Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma. BMC Ophthalmol. 2018;18(1):339. doi:10.1186/s12886-018-0989-6
   PubMedGoogle Scholar
• Sng CC, Wang J, Hau S, Htoon HM, Barton K. XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol. 2018;46(4):339–345. doi:10.1111/ceo.13087
   PubMed Web of Science ®Google Scholar
• Chan TCW, Bala C, Siu A, Wan F, White A. Risk factors for rapid glaucoma disease progression. Am J Ophthalmol. 2017;180:151–157. doi:10.1016/j.ajo.2017.06.003
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Peckar C, Pienaar A, Koerber N, Stegmann R. Long-term results of up to 12 years of over 700 cases of viscocanalostomy for open-angle glaucoma. Acta Ophthalmol. 2015;93(4):362–367. doi:10.1111/aos.12513
   PubMed Web of Science ®Google Scholar
• Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg. 2011;37(4):682–690. doi:10.1016/j.jcrs.2010.10.055
   PubMed Web of Science ®Google Scholar
• Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-casa JM, et al. A randomized trial of a schlemm’s canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–1293. doi:10.1016/j.ophtha.2015.03.031
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. doi:10.1016/j.ophtha.2010.07.007
   PubMed Web of Science ®Google Scholar
• Do A, McGlumphy E, Shukla A, et al. Comparison of clinical outcomes with open versus closed conjunctiva implantation of the XEN45 gel stent. Ophthalmol Glaucoma. 2021;4(4):343–349. doi:10.1016/j.ogla.2020.12.003
   PubMedGoogle Scholar
• Dangda S, Radell JE, Mavrommatis MA, et al. Open conjunctival approach for sub-Tenon’s xen gel stent placement and bleb morphology by anterior segment optical coherence tomography. J Glaucoma. 2021;30(11):988–995. doi:10.1097/ijg.0000000000001929
   PubMed Web of Science ®Google Scholar
• Kong YXG, Chung IY, Ang GS. Outcomes of XEN45 gel stent using posterior small incision sub-tenon ab interno insertion (Semi-open) technique. Eye. 2021;36:1456–1460. doi:10.1038/s41433-021-01635-6
   PubMed Web of Science ®Google Scholar
• Gallardo MJ, Vincent LR, Porter M. Comparison of clinical outcomes following gel stent implantation via ab-externo and ab-interno approaches in patients with refractory glaucoma. Clin Ophthalmol. 2022;16:2187–2197. doi:10.2147/OPTH.S354038
   PubMed Web of Science ®Google Scholar
• Vera V, Gagne S, Myers JS, Ahmed IIK. Surgical approaches for implanting xen gel stent without conjunctival dissection. Clin Ophthalmol. 2020;14:2361–2371. doi:10.2147/opth.s265695
   PubMed Web of Science ®Google Scholar
• Vera V, Ahmed IIK, Stalmans I, Reitsamer H. Gel stent implantation—recommendations for preoperative assessment, surgical technique, and postoperative management. Touch Ophthalmol. 2018;11(1):38–46. doi:10.17925/USOR.2018.11.1.38
   Google Scholar
• Kerr NM, Lim S, Simos M, Ward T. Primary needling of the ab interno gelatin microstent reduces postoperative needling and follow-up requirements. Ophthalmol Glaucoma. 2021;4(6):581–588. doi:10.1016/j.ogla.2021.02.004
   PubMedGoogle Scholar
• Eraslan M, Özcan AA, Dericioğlu V, Çiloğlu E. Multicenter case series of standalone XEN implant vs. combination with phacoemulsification in Turkish patients. Int Ophthalmol. 2021;41(10):3371–3379. doi:10.1007/s10792-021-01899-7
   PubMed Web of Science ®Google Scholar
• Laspas P, Culmann PD, Grus FH, et al. Revision of encapsulated blebs after trabeculectomy: long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures. PLoS One. 2017;12(5):e0178099. doi:10.1371/journal.pone.0178099
   PubMed Web of Science ®Google Scholar
• Rotchford AP, King AJ. Needling revision of trabeculectomies bleb morphology and long-term survival. Ophthalmology. 2008;115(7):1148–1153.e4. doi:10.1016/j.ophtha.2007.10.023
   PubMed Web of Science ®Google Scholar
• Tsai AS, Boey PY, Htoon HM, Wong TT. Bleb needling outcomes for failed trabeculectomy blebs in Asian eyes: a 2-year follow up. Int J Ophthalmol. 2015;8(4):748–753. doi:10.3980/j.issn.2222-3959.2015.04.19
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma preferred practice pattern®. Ophthalmology. 2021;128(1):80. doi:10.1016/j.ophtha.2020.10.022
   Web of Science ®Google Scholar
• Suzuki R, Susanna R. Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective study. Clinics. 2013;68(10):1376–1379. doi:10.6061/clinics/2013(10)14
   PubMed Web of Science ®Google Scholar
• Steiner S, Resch H, Kiss B, Buda D, Vass C. Needling and open filtering bleb revision after XEN-45 implantation-A retrospective outcome comparison. Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2761–2770. doi:10.1007/s00417-021-05204-1
   PubMed Web of Science ®Google Scholar
• Linton E, Au L. Technique of xen implant revision surgery and the surgical outcomes: a retrospective interventional case series. Ophthalmol Ther. 2020;9(1):149–157. doi:10.1007/s40123-020-00234-0
   PubMed Web of Science ®Google Scholar